Janux Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Janux Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q2 2024.
  • Janux Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 54.5M shares, a 30.2% increase year-over-year.
  • Janux Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 44M shares, a 6.14% increase from 2022.
  • Janux Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 41.5M shares, a 76.2% increase from 2021.
  • Janux Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 23.5M shares, a 9967% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 54.5M +12.6M +30.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 49M +7.29M +17.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 44M +2.55M +6.14% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 45.7M +4.18M +10.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 41.8M +387K +0.94% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 41.8M +448K +1.09% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 41.5M +17.9M +76.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 41.5M +392K +0.95% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 41.4M +31.4M +313% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 41.3M +41M +13477% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 23.5M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 41.1M +40.9M +20198% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 10M +9.78M +3829% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 304K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 203K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 255K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.